Related Experiment Video
Updated: Jun 4, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Targeting the Hedgehog pathway in cancer: can the spines be smoothened?
1Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto, Canada.
Abstract:
Aberrant Hedgehog (Hh) pathway signaling has been suggested to play a role in the development of multiple solid tumors and hematologic malignancies. GDC-0449 is a novel first-in-human, first-in-class smoothened (SMO) inhibitor, which has completed its phase I evaluation and achieved proof of concept in tumors with Hh pathway mutations.
Insights
Aberrant Hedgehog pathway signaling is implicated in various cancers. GDC-0449, a novel smoothened inhibitor, has shown proof of concept in tumors with Hedgehog pathway mutations during its initial clinical evaluation.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Aberrant Hedgehog (Hh) pathway signaling is linked to the pathogenesis of numerous solid tumors and hematologic malignancies.
- The Hedgehog pathway plays a critical role in cell growth, differentiation, and tissue repair, and its dysregulation can drive cancer development.
Purpose of the Study:
- To evaluate the safety and efficacy of GDC-0449, a novel first-in-class smoothened (SMO) inhibitor.
- To establish proof of concept for GDC-0449 in patients with tumors harboring Hedgehog pathway mutations.
Main Methods:
- Phase I clinical trial of GDC-0449.
- Assessment of safety, tolerability, and preliminary efficacy in patients with advanced malignancies.
Main Results:
- GDC-0449 is a novel smoothened (SMO) inhibitor that has completed phase I evaluation.
- The drug demonstrated proof of concept in tumors characterized by Hedgehog pathway mutations.
Conclusions:
- GDC-0449 represents a promising therapeutic agent for cancers driven by aberrant Hedgehog pathway signaling.
- Further investigation in clinical trials is warranted to confirm its efficacy and safety profile in specific cancer types.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules

